Cargando…

Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis

Among neurogenerative diseases, amyotrophic lateral sclerosis (ALS) is a fatal illness characterized by a progressive motor neuron dysfunction in the motor cortex, brainstem and spinal cord. ALS is the most common form of motor neuron disease; yet, to date, the exact etiology of ALS remains unknown....

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso, Ruth, Pisa, Diana, Marina, Ana Isabel, Morato, Esperanza, Rábano, Alberto, Rodal, Izaskun, Carrasco, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400386/ https://www.ncbi.nlm.nih.gov/pubmed/25892962 http://dx.doi.org/10.7150/ijbs.11084

Ejemplares similares

Different Brain Regions are Infected with Fungi in Alzheimer’s Disease
por: Pisa, Diana, et al.
Publicado: (2015)

Searching for Bacteria in Neural Tissue From Amyotrophic Lateral Sclerosis
por: Alonso, Ruth, et al.
Publicado: (2019)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Fungal Enolase, β-Tubulin, and Chitin Are Detected in Brain Tissue from Alzheimer’s Disease Patients
por: Pisa, Diana, et al.
Publicado: (2016)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

Human and Microbial Proteins From Corpora Amylacea of Alzheimer’s Disease
por: Pisa, Diana, et al.
Publicado: (2018)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis
por: Nukui, Takamasa, et al.
Publicado: (2021)

Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
por: Bossolasco, Patrizia, et al.
Publicado: (2017)

Corpora Amylacea of Brain Tissue from Neurodegenerative Diseases Are Stained with Specific Antifungal Antibodies
por: Pisa, Diana, et al.
Publicado: (2016)

Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function
por: Drannik, Anna, et al.
Publicado: (2017)

Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
por: Janssens, Jana, et al.
Publicado: (2020)

Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients
por: Sass, Lucas R., et al.
Publicado: (2020)

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression
por: Sol, Joaquim, et al.
Publicado: (2021)

Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients
por: Joilin, Greig, et al.
Publicado: (2022)

Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS
por: Wuolikainen, Anna, et al.
Publicado: (2011)

Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects
por: Wilson, Meghan E, et al.
Publicado: (2013)

Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
por: Bräuer, Stefan, et al.
Publicado: (2020)

Cronobacter sakazakii DNA Detection in Cerebrospinal Fluid of a Patient with Amyotrophic Lateral Sclerosis Mimic Syndrome
por: Piombo, Marianna, et al.
Publicado: (2015)

Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
por: Otake, Kentaro, et al.
Publicado: (2019)

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
por: Tokuda, Eiichi, et al.
Publicado: (2019)

Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
por: Bourbouli, Mara, et al.
Publicado: (2021)

Elevated Cerebrospinal Fluid Proteins and Albumin Determine a Poor Prognosis for Spinal Amyotrophic Lateral Sclerosis
por: Assialioui, Abdelilah, et al.
Publicado: (2022)

Polymicrobial Infections In Brain Tissue From Alzheimer’s Disease Patients
por: Pisa, Diana, et al.
Publicado: (2017)

Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients
por: Mishra, Pooja-Shree, et al.
Publicado: (2016)

YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés-Benito, Pol, et al.
Publicado: (2018)

Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature
por: Gagliardi, Delia, et al.
Publicado: (2019)

Discovery of Biomarkers for Amyotrophic Lateral Sclerosis from Human Cerebrospinal Fluid Using Mass-Spectrometry-Based Proteomics
por: Oh, Sungtaek, et al.
Publicado: (2023)

Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations
por: Lange, Dale J., et al.
Publicado: (2017)

Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés‐Benito, Pol, et al.
Publicado: (2021)

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
por: Abdelhak, Ahmed, et al.
Publicado: (2015)

Fungal-contaminated grass and well water and sporadic amyotrophic lateral sclerosis
por: French, Peter William, et al.
Publicado: (2019)

Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia
por: Mishra, Pooja-Shree, et al.
Publicado: (2017)

Sporadic amyotrophic lateral sclerosis (SALS) – skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model
por: Shanmukha, Shruthi, et al.
Publicado: (2018)

Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid
por: Petrozziello, Tiziana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_snq7kbqnism8s418lh645qd8eg